Drugs / Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd
Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT05158777 Comparator | Feb → Nov 2022 | chickenpox | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 3 | NCT05015686 Comparator | Sep 2021 → Feb 2022 overdue | varicella zoster infection | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05158777 ↗ |
| Modality | Vaccine | “Live Attenuated Varicella Vaccine” NCT05015686 ↗ |